ICU Medical (NASDAQ:ICUI) Shares Down 6% – What’s Next?

ICU Medical, Inc. (NASDAQ:ICUI) fell 6% on Tuesday . The company traded as low as $156.95 and last traded at $157.78. 155,950 shares traded hands during trading, a decline of 43% from the average session volume of 273,648 shares. The stock had previously closed at $167.81.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. KeyCorp upped their target price on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a report on Wednesday, November 13th. Jefferies Financial Group started coverage on shares of ICU Medical in a report on Monday, October 14th. They issued a “hold” rating and a $183.00 price objective for the company. Raymond James boosted their target price on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a report on Thursday, September 12th. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Finally, StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $173.00.

ICU Medical Stock Performance

The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The stock’s 50 day moving average price is $175.98 and its 200 day moving average price is $146.15. The company has a market capitalization of $3.86 billion, a P/E ratio of -34.68 and a beta of 0.66.

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $18,665,666.78. This represents a 10.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Daniel Woolson sold 2,502 shares of ICU Medical stock in a transaction on Friday, August 30th. The shares were sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the sale, the vice president now owns 13,107 shares of the company’s stock, valued at $2,139,324.54. This represents a 16.03 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 38,502 shares of company stock worth $6,573,496. Company insiders own 6.70% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Hexagon Capital Partners LLC raised its position in shares of ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 122 shares during the period. Allworth Financial LP raised its holdings in ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 100 shares during the last quarter. Innealta Capital LLC bought a new position in shares of ICU Medical in the second quarter valued at $32,000. Venturi Wealth Management LLC grew its holdings in shares of ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 302 shares during the last quarter. Finally, Point72 Hong Kong Ltd bought a new stake in shares of ICU Medical during the third quarter worth about $72,000. 96.10% of the stock is owned by institutional investors.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.